Spero Therapeutics Inc
Change company Symbol lookup
Select an option...
SPRO Spero Therapeutics Inc
MFON Mobivity Holdings Corp
XPEV Xpeng Inc
ENVX Enovix Corp
COGT Cogent Biosciences Inc
VONG Vanguard Russell 1000 Growth Index Fund ETF Shares
DPRO Draganfly Inc
BCIM abrdn Bloomberg Industrial Metals Strategy K-1 Free ETF
BCH Banco de Chile
BCEL Atreca Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant (MDR) bacterial infections, and rare diseases where there is unmet medical and patient need. Its lead product candidate, tebipenem pivoxil hydrobromide (tebipenem HBr) is designed to be the first oral carbapenem-class antibiotic for use to treat certain bacterial infections that cause complicated urinary tract infections (cUTIs), including pyelonephritis, caused by certain microorganisms, in adult patients who have limited oral treatment options. Its pipeline also includes SPR720 and SPR206. SPR720 is designed to be the first oral treatment for non-tuberculous mycobacterial (NTM) infection. SPR206 is a direct acting intravenous (IV) administered polymyxin analogue developed from its potentiator platform to treat MDR Gram-negative bacterial infections within the hospital.

Closing Price
$0.8963
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
295,218
0
  • Prev Close
    0.8963
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    295.2K
  • Last (time)
    4:00p ET 08/16/22
  • Last (size)
    2
  • 52-Wk Range
    0.6801 - 19.87
    LowHigh
  • (09/28/21 - 08/02/22)
    31.79%
  • 126.4%
  • Market Cap
    31.4M
  • Shares Outstanding
    35.1M
  • -3.24
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.0
  • 56.39
  • (% of float 07/29/22)
    1.48

Latest News

August 10, 2022
4:05 pm ET
Globe Newswire
August 09, 2022
8:05 am ET
Globe Newswire
July 25, 2022
5:31 pm ET
Newsfile
3:56 pm ET
PR Newswire
2:15 pm ET
Accesswire
1:06 pm ET
Globe Newswire
12:30 pm ET
Accesswire
11:45 am ET
Globe Newswire
11:18 am ET
Accesswire
11:12 am ET
Newsfile
11:00 am ET
BusinessWire
10:51 am ET
PR Newswire
8:45 am ET
Accesswire
7:53 am ET
Newsfile
5:45 am ET
PR Newswire
July 24, 2022
10:15 am ET
Accesswire
July 23, 2022
10:30 am ET
Accesswire
July 22, 2022
3:36 pm ET
Newsfile
2:00 pm ET
BusinessWire
11:30 am ET
Accesswire
11:04 am ET
Newsfile
11:02 am ET
Accesswire
8:45 am ET
Accesswire
8:04 am ET
Newsfile
5:45 am ET
PR Newswire
July 21, 2022
6:01 pm ET
Accesswire
5:34 pm ET
PR Newswire
5:26 pm ET
Globe Newswire
1:30 pm ET
Accesswire
1:00 pm ET
PR Newswire
12:50 pm ET
Globe Newswire
11:00 am ET
Accesswire
9:45 am ET
Accesswire
8:11 am ET
Newsfile
5:45 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.